Aehr Test Systems vs inTEST
AEHR and INTT side by side, both in laboratory apparatus and analytical, optical, measuring, and controlling instruments. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AEHR and INTT compare
Aehr Test Systems is the larger company, worth 11 times as much as inTEST ($1.9B against $176M).
inTEST grew revenue faster over the last twelve months (16.6% versus −15.2% for Aehr Test Systems).
inTEST keeps more of each dollar of sales as profit, with a net margin of 2.7% compared with −14.3% at Aehr Test Systems.
inTEST scores higher on the StockData Score (11 against 6 for Aehr Test Systems), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AEHR | INTT |
|---|---|---|
| Size and price | ||
| Market cap | $1.9B | $176M |
| Share price | $56.98 | $13.73 |
| Change, 1 year | 145% | 64.6% |
| Change, 5 years | 191% | −12.9% |
| Beta (5Y) | 2.51 | 1.36 |
| Employees | 138 | 407 |
| StockData Score | ||
| Total score | 6 | 11 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 0 | 3 (better) |
| Performance score | 0 | 2 (better) |
| Health score | 6 (better) | 5 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | – | 45.8× |
| P/S | 37.2× | 1.3× (better) |
| P/B | 8.4× | 1.6× (better) |
| EV/EBITDA | – | 14.6× |
| FCF yield | −0.29% | −0.14% (better) |
| Fair value | $22.55 | $11.64 |
| Margin of safety | −153% | −17.9% (better) |
| Growth | ||
| Revenue growth (TTM) | −15.2% | 16.6% (better) |
| Revenue growth, 5Y average | 24.7% (better) | 16.2% |
| Profitability | ||
| Gross margin | 35.3% | 44.2% (better) |
| Operating margin | −28.3% | 3.3% (better) |
| Net margin | −14.3% | 2.7% (better) |
| FCF margin | −10.8% | −0.17% (better) |
| Return on equity | −4.1% | 3.5% (better) |
| Return on invested capital | −10.4% | 4.0% (better) |
| Financial health | ||
| Debt / equity | 0.00 | 0.05 (better) |
| Net debt / EBITDA | – | −1.39 |
| Interest coverage | – | 13.3× |
| Current ratio | 7.15 (better) | 2.63 |
| Altman Z-score | 31.07 (better) | 4.48 |
| Piotroski F-score | 3 | 5 (better) |
| Dividends and buybacks | ||
| Buyback yield | −0.12% | – |
| Shareholder yield | −0.12% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 71.3% | 67.3% |
| Held by insiders | 5.0% | 5.7% |
| Insider net buying, 12 months | −$63.1M | −$57.8K (better) |
| Short interest, % of float | 16.9% | 2.8% |
Go deeper
- AEHR stock overview
- AEHR income statement
- AEHR valuation and score
- INTT stock overview
- INTT income statement
- INTT valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.